Search results

Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.

We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.

NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.

Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":

Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.

All the templates and supporting documents you need to make a technology appraisals submission with NICE.

Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.

We’re bringing our guidance together by topic, so that it’s all in one place, clearer to understand and easier to use.

Tell us about an interventional procedure you think should be assessed by NICE.

Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

1 Type 2 diabetes: agreeing my blood glucose (HbA1c) target Patient decision aid c NICE 2022. All rights reserved. Subject to Notice of rights. Last...

Decision aid for Intrabeam radiotherapy system for adjuvant treatment of early breast cancer, TA501 c NICE 2018. All rights reserved. Subject to...

Bisphosphonates for treating osteoporosis Patient decision aid What is osteoporosis and how can bisphosphonates help? Everyone's bones get weaker as...

Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Learning disability settings {"@context":"http://schema

Home Reusing our content...